Evidence map›Paper›PMID 30480706›Full record

ArticleInvestigative ophthalmology & visual science2018

IL-1 and TGF-β Modulation of Epithelial Basement Membrane Components Perlecan and Nidogen Production by Corneal Stromal Cells.

Paramananda Saikia, Shanmugapriya Thangavadivel, Carla S Medeiros, Luciana Lassance, Rodrigo Carlos de Oliveira, Steven E Wilson

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Review
  5. International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Corneal myofibroblasts and fibrosis.Experimental eye research · 2020
    Review
  15. Article
  16. Article
  17. Review
  18. Corneal wound healing.Experimental eye research · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Paramananda SaikiaCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Shanmugapriya ThangavadivelCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Carla S MedeirosCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Luciana LassanceCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Rodrigo Carlos de OliveiraCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Steven E WilsonCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Cleveland Clinic · USCleveland Eye Clinic · US

Funding

RESOURCE/SERVICE CORE C - MOLECULAR INFORMATICS MODULEP30EY025585 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI Brian D Perkins · 2016 to 2026
$7.7M
Corneal Epithelial Growth Factors and ReceptorsR01EY010056 · NEI · UNIVERSITY OF WASHINGTON · PI WILSON, STEVEN EUGENE · 1994 to 2020
$7.4M
VISUAL SCIENCES TRAINING PROGRAMT32EY007157 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Johannes Friedrich von Lintig · 2000 to 2026
$5.5M
Transmission Electron MicroscopeS10RR031536 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI DRAZBA, JUDY · 2011 to 2011
$518k
NCRR NIH HHS S10 RR031536NEI NIH HHS P30 EY025585NEI NIH HHS R01 EY010056NEI NIH HHS T32 EY007157
6 · The paper itself

Abstract

Purpose: To determine whether (1) the in vitro expression of epithelial basement membrane components nidogen-1, nidogen-2, and perlecan by keratocytes, corneal fibroblasts, and myofibroblasts is modulated by cytokines/growth factors, and (2) perlecan protein is produced by stromal cells after photorefractive keratectomy. Methods: Marker-verified rabbit keratocytes, corneal fibroblasts, myofibroblasts were stimulated with TGF-β1, IL-1α, IL-1β, TGF-β3, platelet-derived growth factor (PDGF)-AA, or PDGF-AB. Real-time quantitative RT-PCR was used to detect expression of nidogen-1, nidogen-2, and perlecan mRNAs. Western blotting evaluated changes in protein expression. Immunohistochemistry was performed on rabbit corneas for perlecan, alpha-smooth muscle actin, keratocan, vimentin, and CD45 at time points from 1 day to 1 month after photorefractive keratectomy (PRK). Results: IL-1α or -1β significantly upregulated perlecan mRNA expression in keratocytes. TGF-β1 or -β3 markedly downregulated nidogen-1 or -2 mRNA expression in keratocytes. None of these cytokines had significant effects on nidogen-1, -2, or perlecan mRNA expression in corneal fibroblasts or myofibroblasts. IL-1α significantly upregulated, while TGF-β1 significantly downregulated, perlecan protein expression in keratocytes. Perlecan protein expression was upregulated in anterior stromal cells at 1 and 2 days after -4.5 or -9 diopters (D) PRK, but the subepithelial localization of perlecan became disrupted at 7 days and later time points in -9-D PRK corneas when myofibroblasts populated the anterior stroma. Conclusions: IL-1 and TGF-β1 have opposing effects on perlecan and nidogen expression by keratocytes in vitro. Proximate participation of keratocytes is likely needed to regenerate normal epithelial basement membrane after corneal injury.

Indexed as

AnimalsBasement MembraneBlotting, WesternCorneal KeratocytesCorneal StromaGene Expression RegulationHeparan Sulfate ProteoglycansImmunoenzyme TechniquesInterleukin-1Interleukin-1alphaInterleukin-1betaMembrane GlycoproteinsRabbitsReal-Time Polymerase Chain ReactionRNA, MessengerTransforming Growth Factor betaHeparan Sulfate ProteoglycansInterleukin-1Interleukin-1alphaInterleukin-1betaMembrane GlycoproteinsnidogenperlecanRNA, MessengerTransforming Growth Factor betaTransforming Growth Factor beta1Transforming Growth Factor beta3

Identifiers

PMID30480706
PMCPMC6262649
OpenAlexW2902430806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.